COVID-19

News

US experts trial AZ's long-acting COVID-19 antibody combinat...

An international trial led by US experts is to begin testing AstraZeneca’s long-acting antibody combination therapy to treat COVID-19.

News

EU finalises order for 300 million more Pfizer/BioNTech COVI...

The European Union has rubber-stamped its order for a further 300 million doses of Pfizer/BioNTech’s COVID-19 vaccine, according to press reports.

News

China approves Sinovac's coronavirus vaccine

China’s national regulator has approved Sinovac Biotech’s COVID-19 vaccine for use by the general public.

News

UK targets COVID-19 variants with new order for CureVac jab

The UK has agreed a 50 million-dose order for a COVID-19 vaccine with German biotech CureVac to support development of a shot that specifically targets emerging variants of the virus.

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J asks FDA for emergency clearance for single-shot COVID-1...

Johnson & Johnson’s Janssen unit has filed its single dose COVID-19 vaccine candidate with the FDA, asking for an Emergency Use Authorization (EUA).

News

Veklury rescues Gilead from COVID doldrums in Q4

Gilead’s COVID-19 drug Veklury (remdesivir) is helping the company through disruption caused by the pandemic and patent expiry on two HIV drugs, according to its

US experts trial AZ's long-acting COVID-19 antibody combinat...

EU finalises order for 300 million more Pfizer/BioNTech COVI...

China approves Sinovac's coronavirus vaccine

UK targets COVID-19 variants with new order for CureVac jab

J&J asks FDA for emergency clearance for single-shot COVID-1...

Veklury rescues Gilead from COVID doldrums in Q4

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks